| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type endopeptidase inhibitor activity | 2.34e-05 | 43 | 26 | 3 | GO:0004869 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 3.34e-05 | 143 | 26 | 4 | GO:0017124 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 5.56e-05 | 163 | 26 | 4 | GO:0031072 | |
| GeneOntologyMolecularFunction | ribosome binding | 4.97e-04 | 120 | 26 | 3 | GO:0043022 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 1.61e-03 | 180 | 26 | 3 | GO:0004866 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 1.79e-03 | 187 | 26 | 3 | GO:0030414 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 2.20e-03 | 201 | 26 | 3 | GO:0061135 | |
| GeneOntologyMolecularFunction | ribonucleoprotein complex binding | 2.36e-03 | 206 | 26 | 3 | GO:0043021 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 4.40e-03 | 257 | 26 | 3 | GO:0061134 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid cohesion | 1.23e-05 | 36 | 26 | 3 | GO:0007064 | |
| GeneOntologyBiologicalProcess | smoothened signaling pathway | 6.61e-05 | 176 | 26 | 4 | GO:0007224 | |
| GeneOntologyBiologicalProcess | sister chromatid cohesion | 8.07e-05 | 67 | 26 | 3 | GO:0007062 | |
| GeneOntologyBiologicalProcess | homologous chromosome segregation | 1.27e-04 | 78 | 26 | 3 | GO:0045143 | |
| GeneOntologyBiologicalProcess | cell division | 1.88e-04 | 697 | 26 | 6 | GO:0051301 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | 3.08e-04 | 1091 | 26 | 7 | GO:0033365 | |
| GeneOntologyCellularComponent | axoneme | 4.10e-06 | 207 | 25 | 5 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 4.20e-06 | 208 | 25 | 5 | GO:0097014 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 3.22e-05 | 317 | 25 | 5 | GO:0032838 | |
| GeneOntologyCellularComponent | cytoplasmic region | 5.89e-05 | 360 | 25 | 5 | GO:0099568 | |
| GeneOntologyCellularComponent | cilium | 5.42e-04 | 898 | 25 | 6 | GO:0005929 | |
| MousePheno | decreased pancreatic beta cell proliferation | 4.78e-07 | 11 | 21 | 3 | MP:0011820 | |
| MousePheno | abnormal pancreatic beta cell proliferation | 3.82e-06 | 21 | 21 | 3 | MP:0011818 | |
| MousePheno | decreased pancreatic beta cell mass | 1.41e-05 | 32 | 21 | 3 | MP:0009114 | |
| MousePheno | thymus hyperplasia | 1.70e-05 | 34 | 21 | 3 | MP:0000708 | |
| MousePheno | decreased spleen weight | 2.18e-05 | 113 | 21 | 4 | MP:0004953 | |
| MousePheno | abnormal pancreatic beta cell mass | 4.54e-05 | 47 | 21 | 3 | MP:0009112 | |
| MousePheno | abnormal cell cycle checkpoint function | 1.26e-04 | 66 | 21 | 3 | MP:0004045 | |
| MousePheno | increased grip strength | 2.24e-04 | 387 | 21 | 5 | MP:0010052 | |
| MousePheno | polyuria | 3.05e-04 | 89 | 21 | 3 | MP:0001762 | |
| MousePheno | small spleen | 3.13e-04 | 416 | 21 | 5 | MP:0000692 | |
| MousePheno | increased bleeding time | 3.26e-04 | 91 | 21 | 3 | MP:0005606 | |
| MousePheno | hyperglycemia | 4.96e-04 | 105 | 21 | 3 | MP:0001559 | |
| MousePheno | abnormal pancreatic beta cell morphology | 6.47e-04 | 115 | 21 | 3 | MP:0005217 | |
| MousePheno | decreased IgM level | 6.47e-04 | 115 | 21 | 3 | MP:0001806 | |
| MousePheno | decreased exploration in new environment | 7.94e-04 | 510 | 21 | 5 | MP:0001417 | |
| MousePheno | enlarged thymus | 8.43e-04 | 292 | 21 | 4 | MP:0000709 | |
| MousePheno | abnormal epididymal fat pad morphology | 8.45e-04 | 126 | 21 | 3 | MP:0006319 | |
| MousePheno | reduced female fertility | 8.87e-04 | 296 | 21 | 4 | MP:0001923 | |
| MousePheno | reduced fertility | 1.18e-03 | 844 | 21 | 6 | MP:0001921 | |
| MousePheno | abnormal thymus size | 1.25e-03 | 564 | 21 | 5 | MP:0002364 | |
| MousePheno | abnormal urination | 1.34e-03 | 148 | 21 | 3 | MP:0001756 | |
| MousePheno | abnormal spleen size | 1.36e-03 | 1203 | 21 | 7 | MP:0002224 | |
| MousePheno | abnormal spleen weight | 1.85e-03 | 361 | 21 | 4 | MP:0004951 | |
| MousePheno | abnormal grip strength | 2.12e-03 | 946 | 21 | 6 | MP:0001515 | |
| MousePheno | decreased litter size | 2.23e-03 | 380 | 21 | 4 | MP:0001935 | |
| MousePheno | abnormal exploration in a new environment | 2.29e-03 | 647 | 21 | 5 | MP:0013189 | |
| MousePheno | abnormal litter size | 2.66e-03 | 399 | 21 | 4 | MP:0001933 | |
| MousePheno | increased food intake | 2.70e-03 | 189 | 21 | 3 | MP:0011939 | |
| MousePheno | abnormal pancreatic islet morphology | 2.74e-03 | 190 | 21 | 3 | MP:0005215 | |
| MousePheno | abnormal endocrine pancreas morphology | 2.79e-03 | 191 | 21 | 3 | MP:0009165 | |
| MousePheno | abnormal response to new environment | 2.98e-03 | 687 | 21 | 5 | MP:0001413 | |
| MousePheno | abnormal pancreatic beta cell physiology | 3.00e-03 | 196 | 21 | 3 | MP:0003562 | |
| MousePheno | abnormal physical strength | 3.22e-03 | 1027 | 21 | 6 | MP:0004262 | |
| MousePheno | abnormal endocrine pancreas physiology | 3.26e-03 | 202 | 21 | 3 | MP:0010147 | |
| MousePheno | abnormal hippocampus pyramidal cell morphology | 3.26e-03 | 57 | 21 | 2 | MP:0009940 | |
| Domain | Securin | 1.45e-06 | 2 | 23 | 2 | PF04856 | |
| Domain | Securin_separation_inhibitor | 1.45e-06 | 2 | 23 | 2 | IPR006940 | |
| Domain | Securin_separation-inh_met | 1.45e-06 | 2 | 23 | 2 | IPR018008 | |
| Domain | Metallo-depent_PP-like | 6.18e-04 | 30 | 23 | 2 | IPR029052 | |
| Domain | - | 6.18e-04 | 30 | 23 | 2 | 3.60.21.10 | |
| Pathway | REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1 | 7.40e-05 | 74 | 16 | 3 | MM14678 | |
| Pathway | REACTOME_ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS | 8.34e-05 | 77 | 16 | 3 | MM14692 | |
| Pathway | REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS | 1.20e-04 | 87 | 16 | 3 | MM14677 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING | 1.44e-04 | 16 | 16 | 2 | M47476 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING | 2.50e-04 | 21 | 16 | 2 | M47583 | |
| Pubmed | Identification of disease-relevant modulators of the SHH pathway in the developing brain. | 3.08e-11 | 9 | 26 | 4 | 34463328 | |
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 11682618 | ||
| Pubmed | PTTG is a secretory protein in human pituitary adenomas and in mouse pituitary tumor cell lines. | 3.71e-10 | 3 | 26 | 3 | 17652795 | |
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 33173537 | ||
| Pubmed | Pituitary tumor transforming gene (PTTG) transforming and transactivation activity. | 3.71e-10 | 3 | 26 | 3 | 10713046 | |
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 12626748 | ||
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 28516917 | ||
| Pubmed | PTTG1 Reprograms Asparagine Metabolism to Promote Hepatocellular Carcinoma Progression. | 3.71e-10 | 3 | 26 | 3 | 37159932 | |
| Pubmed | Sex-steroid milieu determines diabetes rescue in pttg-null mice. | 3.71e-10 | 3 | 26 | 3 | 16731783 | |
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 24395789 | ||
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 16959877 | ||
| Pubmed | Characterization of the murine pituitary tumor transforming gene (PTTG) and its promoter. | 3.71e-10 | 3 | 26 | 3 | 10650958 | |
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 23867215 | ||
| Pubmed | The lifespan quantitative trait locus gene Securin controls hematopoietic progenitor cell function. | 3.71e-10 | 3 | 26 | 3 | 31073078 | |
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 34262048 | ||
| Pubmed | Characterization of the pituitary tumor transforming gene 1 knockout mouse retina. | 3.71e-10 | 3 | 26 | 3 | 21203837 | |
| Pubmed | Pituitary tumor transforming gene as a novel regulatory factor of liver fibrosis. | 3.71e-10 | 3 | 26 | 3 | 25936962 | |
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 16322543 | ||
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 36737842 | ||
| Pubmed | Murine pituitary tumor-transforming gene functions as a securin protein in insulin-secreting cells. | 3.71e-10 | 3 | 26 | 3 | 17065388 | |
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 17626243 | ||
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 15281346 | ||
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 20153804 | ||
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 18639540 | ||
| Pubmed | Pituitary hypoplasia in Pttg-/- mice is protective for Rb+/- pituitary tumorigenesis. | 1.48e-09 | 4 | 26 | 3 | 15919720 | |
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 22342753 | ||
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 16030258 | ||
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 23164239 | ||
| Pubmed | Abnormal megakaryocyte development and platelet function in Nbeal2(-/-) mice. | 1.48e-09 | 4 | 26 | 3 | 23861251 | |
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 16720305 | ||
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 17127711 | ||
| Pubmed | Spatial learning and long-term memory impairments in RasGrf1 KO, Pttg1 KO, and double KO mice. | 1.48e-09 | 4 | 26 | 3 | 30259712 | |
| Pubmed | Tumor suppressor activity of KLF6 mediated by downregulation of the PTTG1 oncogene. | 1.48e-09 | 4 | 26 | 3 | 20116377 | |
| Pubmed | Expression of PTTG and prc1 genes during telencephalic neurogenesis. | 1.48e-09 | 4 | 26 | 3 | 10727870 | |
| Pubmed | Pituitary tumor-transforming gene 1 regulates the patterning of retinal mosaics. | 1.48e-09 | 4 | 26 | 3 | 24927528 | |
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 16533944 | ||
| Pubmed | Separase: a universal trigger for sister chromatid disjunction but not chromosome cycle progression. | 1.48e-09 | 4 | 26 | 3 | 16533945 | |
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 17039256 | ||
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 23677169 | ||
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 25421944 | ||
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 19124608 | ||
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 17234588 | ||
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 19477929 | ||
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 35050550 | ||
| Pubmed | Homologue disjunction in mouse oocytes requires proteolysis of securin and cyclin B1. | 1.48e-09 | 4 | 26 | 3 | 14593421 | |
| Pubmed | Securin regulates entry into M-phase by modulating the stability of cyclin B. | 1.48e-09 | 4 | 26 | 3 | 18364698 | |
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 11516952 | ||
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 18417614 | ||
| Pubmed | Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth. | 3.70e-09 | 5 | 26 | 3 | 17975001 | |
| Pubmed | 3.70e-09 | 5 | 26 | 3 | 18981426 | ||
| Pubmed | The meiosis I-to-meiosis II transition in mouse oocytes requires separase activity. | 3.70e-09 | 5 | 26 | 3 | 14561405 | |
| Pubmed | 3.70e-09 | 5 | 26 | 3 | 39093409 | ||
| Pubmed | 3.70e-09 | 5 | 26 | 3 | 21156286 | ||
| Pubmed | PTTG-binding factor (PBF) is a novel regulator of the thyroid hormone transporter MCT8. | 3.70e-09 | 5 | 26 | 3 | 22535767 | |
| Pubmed | 3.70e-09 | 5 | 26 | 3 | 28658604 | ||
| Pubmed | The Rae1-Nup98 complex prevents aneuploidy by inhibiting securin degradation. | 3.70e-09 | 5 | 26 | 3 | 16355229 | |
| Pubmed | 3.70e-09 | 5 | 26 | 3 | 21076990 | ||
| Pubmed | mTOR promotes pituitary tumor development through activation of PTTG1. | 7.41e-09 | 6 | 26 | 3 | 27524416 | |
| Pubmed | 7.41e-09 | 6 | 26 | 3 | 33181265 | ||
| Pubmed | 7.41e-09 | 6 | 26 | 3 | 21991377 | ||
| Pubmed | Loss of Cdc20 causes a securin-dependent metaphase arrest in two-cell mouse embryos. | 1.30e-08 | 7 | 26 | 3 | 17325031 | |
| Pubmed | Nuclear pore protein NUP88 activates anaphase-promoting complex to promote aneuploidy. | 4.43e-08 | 10 | 26 | 3 | 26731471 | |
| Pubmed | 6.09e-08 | 11 | 26 | 3 | 21494564 | ||
| Pubmed | Specificity and Redundancy of Profilin 1 and 2 Function in Brain Development and Neuronal Structure. | 1.06e-07 | 13 | 26 | 3 | 34571959 | |
| Pubmed | 1.06e-07 | 13 | 26 | 3 | 19213844 | ||
| Pubmed | 1.68e-07 | 15 | 26 | 3 | 21163256 | ||
| Pubmed | 2.06e-07 | 16 | 26 | 3 | 18232736 | ||
| Pubmed | 4.89e-07 | 21 | 26 | 3 | 15937080 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 33173433 | ||
| Pubmed | The lncRNA PTTG3P promotes the progression of CRPC via upregulating PTTG1. | 5.37e-07 | 2 | 26 | 2 | 33743960 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 29803224 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 10806349 | ||
| Pubmed | 9.53e-07 | 26 | 26 | 3 | 37727504 | ||
| Pubmed | Notch2 regulates BMP signaling and epithelial morphogenesis in the ciliary body of the mouse eye. | 1.07e-06 | 27 | 26 | 3 | 23676271 | |
| Pubmed | 1.49e-06 | 30 | 26 | 3 | 16420439 | ||
| Pubmed | Proteotyping of knockout mouse strains reveals sex- and strain-specific signatures in blood plasma. | 2.19e-06 | 34 | 26 | 3 | 34050187 | |
| Pubmed | Individual retinal progenitor cells display extensive heterogeneity of gene expression. | 3.88e-06 | 41 | 26 | 3 | 18270576 | |
| Pubmed | 3.93e-06 | 326 | 26 | 5 | 17015433 | ||
| Pubmed | Arid1b haploinsufficiency disrupts cortical interneuron development and mouse behavior. | 1.00e-05 | 56 | 26 | 3 | 29184203 | |
| Pubmed | Transgenerational epigenetic effects imposed by neonicotinoid thiacloprid exposure. | 1.11e-05 | 58 | 26 | 3 | 37973188 | |
| Pubmed | Emergence of young human genes after a burst of retroposition in primates. | 1.01e-04 | 20 | 26 | 2 | 16201836 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 1.72e-04 | 1155 | 26 | 6 | 20360068 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 5.68e-04 | 934 | 26 | 5 | 33916271 | |
| Pubmed | 6.97e-04 | 549 | 26 | 4 | 38280479 | ||
| Coexpression | LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL | 8.31e-07 | 19 | 26 | 3 | MM848 | |
| Coexpression | VIETOR_IFRD1_TARGETS | 2.49e-06 | 27 | 26 | 3 | MM655 | |
| Coexpression | LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN | 5.55e-06 | 35 | 26 | 3 | MM542 | |
| Coexpression | CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE | 9.69e-06 | 42 | 26 | 3 | MM617 | |
| Coexpression | HU_GENOTOXIC_DAMAGE_4HR | 1.04e-05 | 43 | 26 | 3 | MM1204 | |
| Coexpression | LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP | 1.36e-05 | 47 | 26 | 3 | MM539 | |
| Coexpression | BURTON_ADIPOGENESIS_PEAK_AT_24HR | 1.45e-05 | 48 | 26 | 3 | MM1181 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_DN | 1.98e-05 | 164 | 26 | 4 | M2972 | |
| Coexpression | ISHIDA_E2F_TARGETS | 2.20e-05 | 55 | 26 | 3 | MM1264 | |
| Coexpression | GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_DN | 4.23e-05 | 199 | 26 | 4 | M9283 | |
| Coexpression | GUO_HEX_TARGETS_DN | 4.54e-05 | 70 | 26 | 3 | MM629 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN | 4.54e-05 | 70 | 26 | 3 | MM994 | |
| Coexpression | CHESLER_BRAIN_QTL_CIS | 5.81e-05 | 76 | 26 | 3 | MM611 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_DN | 8.69e-05 | 87 | 26 | 3 | MM992 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 1.79e-04 | 111 | 26 | 3 | MM705 | |
| Coexpression | ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR | 2.66e-04 | 127 | 26 | 3 | M2608 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MATURE_ALPHA_BETA_T_CELL_AGEING | 2.99e-04 | 612 | 26 | 5 | MM3804 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SKELETAL_MUSCLE_SATELLITE_CELL_AGEING | 3.26e-04 | 136 | 26 | 3 | MM3747 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_ENDOTHELIAL_CELL_AGEING | 3.93e-04 | 145 | 26 | 3 | MM3744 | |
| Coexpression | KAUFFMANN_DNA_REPLICATION_GENES | 4.01e-04 | 146 | 26 | 3 | M9372 | |
| Coexpression | TABULA_MURIS_SENIS_DIAPHRAGM_MESENCHYMAL_STEM_CELL_AGEING | 5.95e-04 | 397 | 26 | 4 | MM3695 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 6.24e-04 | 402 | 26 | 4 | MM1248 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2 | 7.25e-04 | 179 | 26 | 3 | MM534 | |
| Coexpression | GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_UP | 8.23e-04 | 187 | 26 | 3 | M3287 | |
| Coexpression | JNK_DN.V1_DN | 8.62e-04 | 190 | 26 | 3 | M2745 | |
| Coexpression | GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_UP | 9.16e-04 | 194 | 26 | 3 | M6159 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_DN | 9.43e-04 | 196 | 26 | 3 | M9979 | |
| Coexpression | GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_DN | 9.85e-04 | 199 | 26 | 3 | M6711 | |
| Coexpression | GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_UP | 1.00e-03 | 200 | 26 | 3 | M5093 | |
| Coexpression | GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_DN | 1.00e-03 | 200 | 26 | 3 | M7612 | |
| Coexpression | GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_UP | 1.00e-03 | 200 | 26 | 3 | M7072 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP | 1.00e-03 | 200 | 26 | 3 | M9258 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN | 1.00e-03 | 200 | 26 | 3 | M7900 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN | 1.00e-03 | 200 | 26 | 3 | M7915 | |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_UP | 1.00e-03 | 200 | 26 | 3 | M6019 | |
| Coexpression | GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN | 1.00e-03 | 200 | 26 | 3 | M6552 | |
| Coexpression | GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_DN | 1.00e-03 | 200 | 26 | 3 | M6554 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.63e-07 | 127 | 26 | 4 | aca98d8c91f2aa0a777b6e9480c9ea70d38ff393 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.77e-06 | 152 | 26 | 4 | f748ee34167f79ecda116aa1914afab47403385a | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.68e-05 | 136 | 26 | 3 | c71a02ae8feabb1f51477a7728800b765ef19675 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.91e-05 | 144 | 26 | 3 | 81a18478bc7284b903a4cad67b9049576a8c2b72 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-04 | 174 | 26 | 3 | 2a96a4fd7d9ef05213b26103c689cf3a26968713 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.58e-04 | 182 | 26 | 3 | f549b986caebc5eb1b2d12f34fe33087e8324a31 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.66e-04 | 185 | 26 | 3 | 9d424a8608b339dd6129c58d87626678d4ec4af7 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-04 | 191 | 26 | 3 | 50854384fdaa0efa2e3227659d544ed09ac102f2 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.85e-04 | 192 | 26 | 3 | f518839ecd9377537a414e8798766f7d91eafeac | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.85e-04 | 192 | 26 | 3 | 849ac3c115e6f913e68ca050c308bc4c32cf662b | |
| ToppCell | control-Lymphocytic-Prol._cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.91e-04 | 194 | 26 | 3 | 4c76508de3291c952386caffda2d559629ba5998 | |
| ToppCell | control-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.97e-04 | 196 | 26 | 3 | 886f7c865b086d6ebb4a1746865c30af6bbed345 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Early_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.03e-04 | 198 | 26 | 3 | ecf0a8f2e07f336e23b6f32a2c48d3c7eb66572b | |
| ToppCell | 15-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 2.06e-04 | 199 | 26 | 3 | 5c8b847b794b3e88722f5b841f2539a27251106c | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-04 | 199 | 26 | 3 | 88d130e2451e61afb710edf552e6b346b9fcfb2b | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-T/NK_proliferative|Int-URO / Disease, condition lineage and cell class | 2.09e-04 | 200 | 26 | 3 | 99acc1ea01288efdd5b166aa20d66735f2bbe543 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Fezf2-Excitatory_Neuron.Slc17a7-Slc17a6.Fezf2-3110035E14Rik_(Layer_5,_Retrosplenial_cortex_(RSG)_and_Subiculum,_Tshz2+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.45e-04 | 74 | 26 | 2 | 83b762542508f9d6407e4b0087d70bea81a8fc7d | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chodl_(Low-threshold_spiking_interneuron,_Npy+/Sst+)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.15e-04 | 77 | 26 | 2 | 7bb18406d404c51ee938cc577c155dc51868ddb9 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chodl_(Low-threshold_spiking_interneuron,_Npy+/Sst+)|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.15e-04 | 77 | 26 | 2 | ac311740424ff75b478b3c19fa0fae93776eb54e | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chodl_(Low-threshold_spiking_interneuron,_Npy+/Sst+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.15e-04 | 77 | 26 | 2 | 9f2dbf922acb905d636427a766a217c0db9671d2 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.23e-03 | 121 | 26 | 2 | 4ec70ad316942d9ade7bbdbf0e117e7c52b59d90 | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type | 2.53e-03 | 129 | 26 | 2 | 57b705106aec7bbfc587de1ccd4f2335fc44dd6f | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.73e-03 | 134 | 26 | 2 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.98e-03 | 140 | 26 | 2 | 9f105687f5749399fd76043fd85da58be30f2caf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.98e-03 | 140 | 26 | 2 | a3be1fb7d2eb44bc123456d03250502938d46d9d | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.14e-03 | 144 | 26 | 2 | 57d2846ec26d4490ec11c171af447b17a729437e | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-03 | 147 | 26 | 2 | 743767abdb3b5ecad870b617f515b037ce280818 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.32e-03 | 148 | 26 | 2 | 80470353e12599440f711b6e107730763376d04d | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-DN4_thymocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.36e-03 | 149 | 26 | 2 | 89faa84af68d4727180f39718964bb3bc65d8fe6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.36e-03 | 149 | 26 | 2 | 2624ad3926efc9f0f169daae263cef16861f132b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.45e-03 | 151 | 26 | 2 | b545823113a3450c5f841f7de48bf0937593544f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.45e-03 | 151 | 26 | 2 | 0cc2f4aec3dae4603fa831f22c40f897e68b34e2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.54e-03 | 153 | 26 | 2 | ee6f4770c6e35d59bdeec5b0ecb10119fa8c3ca5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.54e-03 | 153 | 26 | 2 | 90cd6efda83c0b4b80eae2c90e7ff45dfd936dc2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.54e-03 | 153 | 26 | 2 | a35149a0c8b4ec9ad27cc4b3d34fba3b8714a6a2 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.54e-03 | 153 | 26 | 2 | e7d20c88466ff81db613869cf7a6a4bb95fd6c2f | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.54e-03 | 153 | 26 | 2 | 764fb5e5fa028c137b8ea65dcd5e4ec9b22191e9 | |
| ToppCell | (2)_NK/T-(23)_CD4+_T_cell-(230)_CD4+/CD25+_Reg_T_cell|(23)_CD4+_T_cell / immune cells in Peripheral Blood (logTPM normalization) | 3.58e-03 | 154 | 26 | 2 | 059bdf6843f94f5028d4df6aa025865a9edb4521 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.63e-03 | 155 | 26 | 2 | afdd0aba0f3788c2fb916ffb453c5dd7cde2304c | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.68e-03 | 156 | 26 | 2 | abea3c183d32062b009a79a2bdf861021989c7ef | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.68e-03 | 156 | 26 | 2 | fbe23876f0899853cea3c5c4f3044a9cea064d5b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.72e-03 | 157 | 26 | 2 | 29622bac6b16bb39cec4319bf4c4f92d33345e8a | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.72e-03 | 157 | 26 | 2 | abfd05ed993b80822739f47a735f154092a23632 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.77e-03 | 158 | 26 | 2 | c08b5e12cc2975e52965e22ec987d0d45a9a68e9 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.82e-03 | 159 | 26 | 2 | b05fda31b77536a1878f55d3199563b53f9420b2 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.82e-03 | 159 | 26 | 2 | ae53ab7a1339007d0b245c6c291ac61e5ff5b682 | |
| ToppCell | IIF-Lymphocyte-T_NK-CD4_CTL|IIF / Disease, Lineage and Cell Type | 3.82e-03 | 159 | 26 | 2 | 64e2b57e09bf25b2582f154375bb88cfd02a2521 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-03 | 159 | 26 | 2 | 656aa20706bdba81bbcc3e68e6058215b92b8802 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Neutrophil|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-03 | 160 | 26 | 2 | 7af3fbe555ff2eb1272381411617646e9e8c0440 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.91e-03 | 161 | 26 | 2 | b24293fdae9637983fcf4f2d4659a3554e00a53f | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.91e-03 | 161 | 26 | 2 | eddcbe266d4a84a340fa8f2128d2b7e293968dca | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.00e-03 | 163 | 26 | 2 | fd35f1237c23367753ac2bc3e893f0e3c714129c | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.00e-03 | 163 | 26 | 2 | 00e791358a7eb6c3e95f87afe22153845012e4a1 | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Seminoma-_NOS|TCGA-Testes / Sample_Type by Project: Shred V9 | 4.00e-03 | 163 | 26 | 2 | 67551fefe22bd5b8178fa248fed2a6c17b19fb0f | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Seminoma-_NOS-5|TCGA-Testes / Sample_Type by Project: Shred V9 | 4.00e-03 | 163 | 26 | 2 | 80bc3732afd8501938753120b8403098c7c5e928 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.10e-03 | 165 | 26 | 2 | 60b500eb2c10cccf309b8fb28a9119da22d6889c | |
| ToppCell | severe_influenza-CD4+_CTL|World / disease group, cell group and cell class (v2) | 4.15e-03 | 166 | 26 | 2 | cdc3e200373718f26fe02ee516928097103f46e2 | |
| ToppCell | Dividing_Macrophages-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 4.15e-03 | 166 | 26 | 2 | ea95b94ccc2ac67df741b30c27f4ae698925875f | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 4.20e-03 | 167 | 26 | 2 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.20e-03 | 167 | 26 | 2 | 315cde87eed2b42a1b9b068fae94caa10ec64c70 | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-03 | 167 | 26 | 2 | 961e722442d786ab15d1e490941d2be265a9057a | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-03 | 167 | 26 | 2 | 3760efc35d4e7e9c2da1a20f9795ddea397e2206 | |
| ToppCell | mild_COVID-19-Treg|World / disease group, cell group and cell class (v2) | 4.20e-03 | 167 | 26 | 2 | 69330689b6e353c8ee9ea1b63a5eac6ab38d456f | |
| ToppCell | COVID-19_Moderate-Treg|COVID-19_Moderate / disease group, cell group and cell class | 4.20e-03 | 167 | 26 | 2 | 4ddb21421cbe72c06b61dd3a5eb1337e59de42e5 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.25e-03 | 168 | 26 | 2 | c7021748003e5949f7caf7b3291c5bad294948c1 | |
| ToppCell | severe_influenza-CD4+_CTL|severe_influenza / disease group, cell group and cell class (v2) | 4.25e-03 | 168 | 26 | 2 | 50697fda702a09d9a621e9f79c2b52d53792dd2a | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.25e-03 | 168 | 26 | 2 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Tnaive/CM_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.25e-03 | 168 | 26 | 2 | c51244b4bdbfd961e2725306aa9cb25dd66d58bd | |
| ToppCell | Dividing_Macrophages-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 4.30e-03 | 169 | 26 | 2 | eb0c993ef2eea73bc4881182520922ce9ae9368f | |
| ToppCell | Dividing_Macrophages-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 4.30e-03 | 169 | 26 | 2 | bc859a103cad567caf50c3c3882d2d2017807c73 | |
| ToppCell | severe_influenza-gd_T|World / disease group, cell group and cell class (v2) | 4.30e-03 | 169 | 26 | 2 | 6d514dd2d1e5253bce49279f43aa2fa2b7c2653e | |
| ToppCell | Mild-Treg|World / Disease group and Cell class | 4.35e-03 | 170 | 26 | 2 | f3f177534badca34e1ae8671b7f583ee6688e14b | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-03 | 171 | 26 | 2 | 43d8fd9b9546e84a652564fe96b514b34b06262b | |
| ToppCell | T_cells-GNLY+GZMB+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.40e-03 | 171 | 26 | 2 | 04c811817cfec45af5f2891793106cc7ddb0300e | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.40e-03 | 171 | 26 | 2 | 4ccd88cf812dd8bfdc55159c6f504e9c84e4f4fc | |
| ToppCell | NS-critical-d_0-4-Lymphoid-B_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.40e-03 | 171 | 26 | 2 | bd1ebd9037a740ad8c01c460d778b0973d8b56df | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-03 | 171 | 26 | 2 | a31c23406cf6d6a17358a8fb41d392a7fb0306e0 | |
| ToppCell | mild_COVID-19-Treg|mild_COVID-19 / disease group, cell group and cell class (v2) | 4.45e-03 | 172 | 26 | 2 | 77af6324c06b67867e7ce07706536fe38de5ed7b | |
| ToppCell | IIH-CD8-CD8_2|IIH / Condition, Cell_class and T cell subcluster | 4.45e-03 | 172 | 26 | 2 | 1466cb4298c63e995b3368d296b254e0e76a1b41 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.45e-03 | 172 | 26 | 2 | 7f3d0ef18f5df1ed80498d435b0378ca398c0b88 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.45e-03 | 172 | 26 | 2 | e9095c3dac66cf93d31f5f88364b565abacb1e2d | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.50e-03 | 173 | 26 | 2 | b6bb2a136a40f0946bbcde8d5972d3f059d080c7 | |
| ToppCell | control-Lymphocytic-CD4_T_cells_3|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.50e-03 | 173 | 26 | 2 | 0c9fb18536ddd61b51b7bb4d40841f67b017f360 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.55e-03 | 174 | 26 | 2 | b6725086fe5a2b057c7c495ec63c970ac52c2580 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.55e-03 | 174 | 26 | 2 | e70cc623a3a6aceec813ed852fec0c4240561133 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.55e-03 | 174 | 26 | 2 | 271c51d220842402975d97c86c9acfdbdf62a32c | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.55e-03 | 174 | 26 | 2 | 9bb8159a62640756d18ecbade3bf32bcbb7dd590 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.55e-03 | 174 | 26 | 2 | 46cbb462173a684ceb9e680f9259dc3b133763f7 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.60e-03 | 175 | 26 | 2 | 26bd957498e41a3f1ffa60d3effa27ca8c4ba631 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.60e-03 | 175 | 26 | 2 | 41174b7381932a2cc94063c7202eeff6d3208cc7 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-stromal_related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.60e-03 | 175 | 26 | 2 | b8995e7ada85ba959f06264a0295b61e390c4e6c | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.60e-03 | 175 | 26 | 2 | 6b4e841bde6cfa4956e1a0231672cea20f11210c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-stromal_related-T_reticular|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.60e-03 | 175 | 26 | 2 | 7ae76bd3b4f610b2f98716a4456437cd3696b686 | |
| ToppCell | (2)_NK/T-(23)_CD4+_T_cell-(232)_CD4+/CD45RA+_Naive_T_cell|(23)_CD4+_T_cell / immune cells in Peripheral Blood (logTPM normalization) | 4.60e-03 | 175 | 26 | 2 | fc40fda0fb9954cb0970c6ac71f6d6df7d27dc5c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.60e-03 | 175 | 26 | 2 | 16c835e62a3321f6cf6163954889946bbb869498 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-regulatory_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.65e-03 | 176 | 26 | 2 | 856a8c4211ea33d926b18d8959a03909562aa563 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 4.65e-03 | 176 | 26 | 2 | a40dfd8c4ba16757ff929b2f03a0628acf334de4 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.70e-03 | 177 | 26 | 2 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.70e-03 | 177 | 26 | 2 | 4672cc75225a4a23b298afa8ce439628262519db | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.70e-03 | 177 | 26 | 2 | 3081ce5fc66a1bb833719d6c0e0a6fc7115eeb91 | |
| Disease | Neurodevelopmental Disorders | 2.59e-03 | 93 | 24 | 2 | C1535926 | |
| Disease | Psychotic Disorders | 3.05e-03 | 101 | 24 | 2 | C0033975 | |
| Disease | Papillary Renal Cell Carcinoma | 4.84e-03 | 128 | 24 | 2 | C1306837 | |
| Disease | Renal Cell Carcinoma | 4.84e-03 | 128 | 24 | 2 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 4.84e-03 | 128 | 24 | 2 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 4.84e-03 | 128 | 24 | 2 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 4.84e-03 | 128 | 24 | 2 | C1266044 | |
| Disease | Intellectual Disability | 5.52e-03 | 447 | 24 | 3 | C3714756 | |
| Disease | Sclerocystic Ovaries | 6.08e-03 | 144 | 24 | 2 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 6.08e-03 | 144 | 24 | 2 | C0032460 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 6.42e-03 | 148 | 24 | 2 | C0279702 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WNISLPTVPKPPPKP | 176 | P17405 | |
| PPPPPVGWGTPKVTR | 376 | Q3SXY8 | |
| PQVPKGLKNPPGPWG | 31 | P04798 | |
| SWKPPPPPQSTKPSF | 1201 | Q8ND23 | |
| KQPRKPPQPPGPCWF | 316 | Q69YN2 | |
| PSPPAKKPWSQQPDP | 171 | C9JE40 | |
| KTGFPWPPSGKPLLP | 921 | A1KZ92 | |
| WPPQAKPPPKACTQP | 1131 | O14976 | |
| PCKSTQPKPSQPWPP | 986 | Q9BX69 | |
| YNPIPWKPIHMPPPK | 316 | Q96HJ3 | |
| PAKPAPSVSPGPWKP | 336 | Q96JM3 | |
| LPAPSPGWTSSPKPP | 926 | O00512 | |
| STEPPAPKAPRPKWP | 236 | Q8TBE0 | |
| PPTLWPSPAPGKPQK | 1931 | A6NE01 | |
| LGPPSPVKMPSPPWE | 161 | O95997 | |
| SPWIVKKPPSLPPPA | 166 | Q8NE09 | |
| LGPPSPLKMPSPPWK | 161 | Q9NZH4 | |
| LGPPSPVKMPSPPWE | 161 | Q9NZH5 | |
| FQNWPKPPLPPLPTG | 1941 | Q9Y566 | |
| ESKPPPPGWRPKGLL | 971 | Q99570 | |
| PLWIGKPGDKPPPLC | 131 | Q96ES7 | |
| PSPPKPKTIVLPPNW | 2381 | Q9BYW2 | |
| PLKPRPEPPKKPSNW | 66 | Q96GY0 | |
| PPPGLTNPKPSSPWS | 1601 | Q9UPQ9 | |
| PASSWKPPPGLAPPQ | 426 | Q8N5Q1 | |
| PPWDPKGPPKVPFRS | 786 | Q8N5Q1 | |
| WAPTPPAATPPSPKG | 961 | E9PAV3 |